Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 413-422

  Ka, Hakhyun ^a   Hunt, Joan S ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; NEURONAL APOPTOSIS INHIBITORY PROTEIN; PARAFORMALDEHYDE; PROTEIN HIAP 1; PROTEIN HIAP 2; PROTEIN JAR; PROTEIN JEG 3; PROTEIN LIVIN; SURVIVIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CHORIOCARCINOMA; CYTOTROPHOBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST;

EID: 0042847096     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63671-1     Document Type: Article

References (41)

1. Strasser A, O'Connor L, Dixit VM: Apoptosis signaling. Annu Rev Biochem 2000, 69:217-245
2. Bortner CD, Cidlowski JA: Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol 2002, 42:259-281
3. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995, 83:1243-1252
4. Deveraux QL, Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 1999, 13:239-252
5. Verhagen AM, Coulson EJ, Vaux DL: Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2001, 2:3009.1-3009.10
6. Kasof GM, Gomes BC: Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001, 276:3238-3246
7. Chen Z, Naito M, Hori S, Mashima T, Yamori T, Tsuruo T: A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun 1999, 264:847-854
8. Mayhew TM, Leach L, McGee R, Ismail WW, Myklebust R, Lammiman MJ: Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta 1999, 20:407-422
9. Huppertz B, Tews DS, Kaufmann P: Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol 2001, 205:215-253
10. DiFederico E, Genbacev O, Fisher SJ: Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999, 155:293-301
11. Smith SC, Baker PN, Symonds EM: Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997, 177:57-65
12. Kudo T, Izutsu T, Sato T: Telomerase activity and apoptosis as indicators of ageing in placenta with and without intrauterine growth retardation. Placenta 2000, 21:493-500
13. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002, 186:158-166
14. Huppertz B, Frank HG, Kingdom JC, Reister F, Kaufmann P: Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998, 110:495-508
15. Ratts VS, Tao XJ, Webster CB, Swanson PE, Smith SD, Brownbill P, Kraiewski S, Reed JC, Tilly JL, Nelson DM: Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 2000, 21: 361-366
16. Gruslin A, Qiu Q, Tsang BK: X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development. Biol Reprod 2001, 64:1264-1272
17. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss III JF: Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986, 118:1567-1582
18. Douglas GC, King BF: Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods 1989, 119:259-268
19. Parham P, Barnstable CJ, Bodmer WF: Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J Immunol 1979, 123:342-349
20. Phillips TA, Ni J, Hunt JS: Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 2001, 22:663-672
21. Yelavarthi KK, Chen HL, Yang YP, Cowley Jr BD, Fishback JL, Hunt JS: Tumor necrosis factor-α mRNA and protein in rat uterine and placental cells. J Immunol 1991, 146:3840-3848
22. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS: Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991, 139:327-335
23. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997, 82:3173-3175
24. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S: Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 1996, 81:3119-3122
25. Phillips TA, Ni J, Pan G, Ruben SM, Wei YF, Pace JL, Hunt JS: TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 1999, 162:6053-6059
26. Gill RM, Ni J, Hunt JS: Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes. Am J Pathol 2002, 161:2011-2017
27. Yui J, Hemmings D, Garcia-Lloret M, Guilbert LJ: Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction. Biol Reprod 1996, 55:400-409
28. Yelavarthi KK, Hunt JS: Analysis of p60 and p80 tumor necrosis factor-α receptor messenger RNA and protein in human placentas. Am J Pathol 1993, 143:1131-1141
29. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308
30. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW: Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci USA 1997, 94:10057-10062
31. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J: Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 1998, 188:211-216
32. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS: NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683
33. Xiao CW, Ash K, Tsang BK: Nuclear factor-κB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor α-induced apoptosis. Endocrinology 2001, 142:557-563
34. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A: Inhibition of JNK activation through NF-κB target genes. Nature 2001, 414:313-317
35. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ: Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994, 15:819-835
36. Genbacev O, McMaster MT, Fisher SJ: A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiation. Am J Pathol 2000, 157:1337-1351
37. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584
38. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K, Shiraki K: Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16 (INK4a) and Cdk2/cyclin E complex activation. Oncogene 2000, 19:3225-3234
39. Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR: Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 2001, 97:965-970
40. Runic R, Lockwood CJ, LaChapelle L, Dipasquale B, Demopoulos RI, Kumar A, Guller S: Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab 1998, 83:660-666
41. Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, Cerami A: Infection and labor, IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989, 161:336-341